Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of September 18. Aside from presenting a synopsis of events, we provide
There is growing evidence that a relative abundance of certain gut microbes may be related to skeletal health, according to a new study published in
It is well known that sleep is the best medication. However, it is still unknown why the brain recovers better in sleep and whether these
The CDC’s vaccine advisors on Friday afternoon voted 11-1 to recommend Pfizer’s maternal RSV vaccine for pregnant people at 32 to 36 weeks of gestation
Novo Nordisk’s diabetes treatment Ozempic could be the drug industry’s second-highest seller in 2024, according to Evaluate’s latest forecast, as analysts and physicians signal the
Boehringer Ingelheim and Eli Lilly nabbed a second FDA approval for blockbuster Jardiance (empagliflozin), this time to treat adults with chronic kidney disease, the companies
Democrat Sens. Ed Markey of Massachusetts and Joe Manchin of West Virginia are calling on FDA Commissioner Rob Califf not to permit the use of
Morphic Therapeutic saw its shares $MORF slide by 25% Friday to about $38 after data from a small Phase IIa trial showed its inflammatory bowel
The roster of college athletes at Dexcom U is growing as the blood sugar monitoring company recruits another 11 players for sponsorships. Now in the
I2o Therapeutics CEO Kurt Graves set out on Thursday to make a case to a panel of the FDA’s expert advisors that the benefits of